Market Research Logo

Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate cancer, colorectal cancer, and lung cancer.

The oncology diagnostics market is experiencing consolidation between the major pharma and diagnostic participants who are collaborating to devise and implement disruptive technologies for cancer diagnosis. The research focuses on highlighting some of the major trends occurring in the market alongside these strategic partnerships. Furthermore, emphasis is on the key challenges in the European market in terms of regulations pertaining to companion diagnostics for cancer detection and monitoring. The deliverable outlines some of the major drivers and restraints, impact analysis of major growth opportunities, as well as market engineering measurements.

With early detection being a key imperative in oncology diagnosis, the study highlights some of the major technology trends in the market with the application of Artificial Intelligence and Big Data as well as Liquid Biopsy and Next Generation Sequencing, which are expected to reduce the turnaround time for cancer detection, thus speeding up the treatment uptake. Emphasis is given to the emerging biomarkers across the types of cancer, which are expected to aid in faster and easier diagnosis of the disease. Furthermore, analysis is provided for the key participants that are working towards devising new solutions which help to detect these biomarkers, thereby supporting accurate detection and monitoring. In addition to the key participants across the market, new market entrants by different cancer types have been profiled.

Some of the key questions answered by the study include:
• How is the market attractiveness for oncology diagnostics building up over the years? What is the future market potential?
• How is the adoption of technology affecting the European oncology diagnostic market?
• Which are the disruptions affecting the value chain equilibrium?
• How are the new technology trends impacting service providers?
• How is the changing economic scenario affecting the regional market? Which are the most opportune markets in Europe?
• What is the application of companion diagnostics on the overall market? How is it expected to impact the market over the next few years?


  • Executive Dashboard
    • Purpose of this Experiential Study
    • 5-Step Process to Transformational Growth
    • Strategic Imperatives for Oncology Diagnostics Market
    • Scope and Segmentation
    • Key Questions to be Answered
    • Market Engineering Measurements
    • Big Market Themes
  • Growth Environment—Market Overview
    • Methodology
    • Industry Ecosystem
    • Key Trends and Impact on Business
    • Market Drivers and Restraints
    • Industry Challenges
    • Legislative Framework for Genetic Testing in EU5
  • Growth Environment—Total Oncology Diagnostics Market Forecasts
    • Market Engineering Measurements
      • Table Total Oncology Diagnostics Market: Market Engineering Measurements, W. Europe, 2016
    • Forecast Assumptions
    • Revenue Forecast by Cancer Type
      • Table Total Oncology Diagnostics Market: Revenue Forecast by Cancer Type, W. Europe, 2013–2021
    • Revenue Forecast Discussion
  • Growth Environment—Breast Cancer Diagnostics Segment
    • Segmentation by Technology and Function
    • Breast Cancer Diagnostic Pathway
    • Revenue Forecast by Country
      • Table Breast Cancer Diagnostics Segment: Revenue Forecast by Country, W. Europe, 2013–2021
    • Revenue Forecast by Technology
      • Table Breast Cancer Diagnostics Segment: Revenue Forecast by Technology, W. Europe, 2013–2021
    • Revenue Forecast Discussion
    • Competitor Scenario and Market Share Analysis
      • Table Market Share Analysis
    • Key Companies to Watch
    • Emerging Technologies in Breast Cancer Diagnostics
    • Country-wise Highlights
  • Ovarian Cancer Diagnostics Segment
    • Segmentation by Technology and Function
    • Ovarian Cancer Diagnostic Pathway
    • Revenue Forecast by Country
      • Table Ovarian Cancer Diagnostics Segment: Revenue Forecast by Country, W. Europe, 2013–2021
    • Revenue Forecast by Technology
      • Table Ovarian Cancer Diagnostics Segment: Revenue Forecast by Technology, W. Europe, 2013–2021
    • Revenue Forecast Discussion
    • Competitor Scenario and Market Share Analysis
      • Table Market Share Analysis
    • Key Companies to Watch
    • Emerging Technologies in Ovarian Cancer Diagnostics
    • Country-wise Highlights
  • Cervical Cancer Diagnostics Segment
    • Segmentation by Technology and Function
    • Cervical Cancer Diagnostic Pathway
    • Revenue Forecast by Country
      • Table Cervical Cancer Diagnostics Segment: Revenue Forecast by Country, W. Europe, 2013–2021
    • Revenue Forecast by Technology
      • Table Cervical Cancer Diagnostics Segment: Revenue Forecast by Technology, W. Europe, 2013–2021
    • Revenue Forecast Discussion
    • Competitor Scenario and Market Share Analysis
      • Table Market Share Analysis
    • Key Companies to Watch
    • Emerging Technologies in Cervical Cancer Diagnostics
    • Country-wise Highlights
  • Prostate Cancer Diagnostics Segment
    • Segmentation by Technology and Function
    • Prostate Cancer Diagnostic Pathway
    • Revenue Forecast by Country
      • Table Prostate Cancer Diagnostics Segment: Revenue Forecast by Country, W. Europe, 2013–2021
    • Revenue Forecast by Technology
      • Table Prostate Cancer Diagnostics Segment: Revenue Forecast by Technology, W. Europe, 2013–2021
    • Revenue Forecast Discussion
    • Competitor Scenario and Market Share Analysis
      • Table Market Share Analysis
    • Key Companies to Watch
    • Emerging Technologies in Prostate Cancer Diagnostics
    • Country-wise Highlights
  • Lung Cancer Diagnostics Segment
    • Segmentation by Technology and Function
    • Lung Cancer Diagnostic Pathway
    • Revenue Forecast by Country
      • Table Lung Cancer Diagnostics Segment: Revenue Forecast by Country, W. Europe, 2013–2021
    • Revenue Forecast by Technology
      • Table Lung Cancer Diagnostics Segment: Revenue Forecast by Technology, W. Europe, 2013–2021
    • Revenue Forecast Discussion
    • Competitor Scenario and Market Share Analysis
      • Table Market Share Analysis
    • Key Companies to Watch
    • Emerging Technologies in Lung Cancer Diagnostics
    • Country-wise Highlights
  • Colorectal Cancer Diagnostics Segment
    • Segmentation by Technology and Function
    • Colorectal Cancer Diagnostic Pathway
    • Revenue Forecast by Country
      • Table Colorectal Cancer Diagnostics Segment: Revenue Forecast by Country, W. Europe, 2013–2021
    • Revenue Forecast by Technology
      • Table Colorectal Cancer Diagnostics Segment: Revenue Forecast by Technology, W. Europe, 2013–2021
    • Revenue Forecast Discussion
    • Competitor Scenario and Market Share Analysis
      • Table Market Share Analysis
    • Key Companies to Watch
    • Emerging Technologies in Colorectal Cancer Diagnostics
    • Country-wise Highlights
  • Growth Environment—Competitive Playbook
    • EU Competitive Landscape by Technology
    • Competitive Environment
    • Competitive Factors and Assessment
    • Competitive Playbook—Key Market Participants by Country
    • Key M&A Assessment
  • Visioning Scenarios
    • Oncology Diagnostics Market—Macro to Micro Visioning
  • Future Outlook and Emerging Opportunities—CDx, Liquid Biopsy, and NGS
    • Companion Diagnostics—Reimbursement Overview across Western Europe
    • Companion Diagnostics—Reimbursement Challenges
    • Companion Diagnostics—An Opportunity
    • Liquid Biopsy—A Step Ahead in Biomarker Analysis
    • Recent Events in Liquid Biopsy Segment
    • Top 3 Predictions for the Market
  • Growth Pipeline—Growth Opportunities
    • 5 Major Growth Opportunities
    • Growth Opportunities Impact Analysis
    • Growth Opportunity 1—Artificial Intelligence (AI)
    • Growth Opportunity 2—Real-time Diagnostics
    • Growth Opportunity 3—Genetic Testing and Biomarkers
    • Growth Opportunity 4—Point-of-care Testing
    • Growth Opportunity 5—Next Generation Sequencing (NGS)
  • The Last Word
  • Appendix
    • List of Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report